BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Wallerian Degeneration

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Wallerian Degeneration:

Pubmed Logo
Minocycline protects Schwann cells from ischemia-like injury and promotes axonal outgrowth in bioartificial nerve grafts lacking Wallerian degeneration.
Minocycline, a broad-spectrum antimicrobial tetracycline, acts...
18th July, 2008
Institute of Medical Neurobiology, University of Magdeburg, Leipziger Exp Neurol. 2008 Jul;212(1):189-200. Epub 2008 Apr 15.
DOI Direct Link
Acute energy restriction triggers Wallerian degeneration in mouse.
Acute exposure of peripheral axons to the free radical Nitric Oxide (NO)...
18th July, 2008
Division of Neuroscience and Pharmacology, Panum Institute, Faculty of Exp Neurol. 2008 Jul;212(1):166-78. Epub 2008 Apr 8.
DOI Direct Link
Control of glial precursor cell development in the mouse optic nerve by sonic hedgehog from retinal ganglion cells.
The development of glial precursor cells in the mammalian optic nerve...
16th July, 2008
Molecular Medicine Program, Ottawa Health Research Institute, 501 Smyth Brain Res. 2008 Jun 24;.
DOI Direct Link
Neuronal maturation-associated resistance of neurite degeneration caused by trophic factor deprivation or disrupting agents.
Neurite (axon and dendrite) degeneration requires self-destructive...
16th July, 2008
Molecular Neurobiolm 9512, Sapporo 060-0810, Japan. Brain Res. 2008 Jun 28;.
DOI Direct Link
Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia.
The removal of degenerated myelin is essential for repair in Wallerian...
11th July, 2008
Department of Anatomy and Cell Biology, Hebrew University Faculty of Glia. 2008 Jul 9;.
DOI Direct Link

View more research publications.

BioNews Results for Wallerian Degeneration:

RSS Logo
BioPortfolio Logo
Clinical Trial Update
Retinal Physician:  Jul 18 2008 5:00PM Matching: degeneration
Protein Transports Nutrients Believed to Protect Against Eye Disease
Newswise:  Jul 17 2008 7:48PM Matching: degeneration
Nanoparticle Research in Review of Ophthalmology
Newswise:  Jul 17 2008 11:13AM Matching: degeneration
Nanoparticles: Into the New Frontier
Review of Ophthalmology:  Jul 16 2008 7:19AM Matching: degeneration
Pipex Sees Strong Data for Dry Age-Related Macular Degeneration Trial
FDA News:  Jul 16 2008 12:41AM Matching: degeneration
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Wallerian Degeneration Patents:

USPTO Logo
US Patent No.Title
6379313 Methods for the assessment of neuromuscular function by F-wave latency
6667156 Diagnosis and treatment of neuroectodermal tumors
6673832 Methods for identifying compounds for treating pain
6692444 Methods for the assessment of neuromuscular function by F-wave latency
6706764 Use of creatine or creatine analogs for the treatment of diseases of the nervous system

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Wallerian Degeneration scientists - we have details of around 195 individuals working on Wallerian Degeneration .


This page has been viewed 117 times
Recent Search Terms used to find this page: wallerian degeneration | Wallerian degeneration | wallerian degeneration | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Wallerian Degeneration across BioPortfolio, or bestselling Wallerian Degeneration books or recently published Wallerian Degeneration books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional